Pearce Samantha 4

What Happened

• Samantha Pearce, EVP and Chief Commercial Officer of Jazz Pharmaceuticals (JAZZ), had 2,503 shares withheld to cover tax obligations tied to vesting of restricted stock units. The shares were valued at $188.69 each, for a total of about $472,291. This is a routine tax-withholding disposition (not an open-market sale).

Key Details

• Transaction date and price: March 5, 2026 — 2,503 shares at $188.69 per share.
• Transaction type/code: F (shares withheld to satisfy tax obligations arising from vesting of RSUs).
• Shares owned after transaction: Not specified in the excerpt of the filing.
• Footnote: F1 — Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
• Filing date: March 9, 2026. The filing does not indicate a late-report flag.

Context

• This was a tax-withholding disposition tied to RSU vesting (common practice) rather than a discretionary sale; such withholdings are routine and do not necessarily signal the insider’s view on the company’s stock.
• Purchases or open-market sales are generally more informative about insider sentiment than tax withholding events.